Patents by Inventor Mary E. Abood

Mary E. Abood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)
    Patent number: 9622995
    Abstract: Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: April 18, 2017
    Assignees: TEMPLE UNIVERSITY—Of The Commonwealth System of Higher Education, DUKE UNIVERSITY, RESEARCH TRIANGLE INSTITUTE
    Inventors: Mary E. Abood, Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman
  • TREATMENT OF DISORDERS ASSOCIATED WITH G PROTEIN-COUPLED RECEPTOR 35 (GPR35)
    Publication number: 20150265561
    Abstract: Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
    Type: Application
    Filed: May 13, 2015
    Publication date: September 24, 2015
    Inventors: Mary E. Abood, Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman
  • Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)
    Patent number: 9040583
    Abstract: Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
    Type: Grant
    Filed: July 14, 2010
    Date of Patent: May 26, 2015
    Assignees: Temple University-Of the Commonwealth System of Higher Education, Duke University, Research Triangle Institute
    Inventors: Mary E. Abood, Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman
  • TREATMENT OF DISORDERS ASSOCIATED WITH G PROTEIN-COUPLED RECEPTOR 35 (GPR35)
    Publication number: 20120122987
    Abstract: Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
    Type: Application
    Filed: July 14, 2010
    Publication date: May 17, 2012
    Applicants: Temple University of the Commonwealth System of Higher Education, Research Triangle Institute, Duke University
    Inventors: Mary E. Abood, Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman
  • Use of anandamide/cannabinoid receptor/acceptor agonists in als screening and treatment methods
    Publication number: 20040018151
    Abstract: In one aspect of the present invention, a method of screening for compounds useful for promoting normal motor function in ALS patients is provided. The screening method comprises (a) administering a compound that is a anandamide/cannabinoid receptor/acceptor agonist to a mammal having observable motor function, and (b) evaluating one or more indicia of motor function in said mammal, wherein a compound that promotes normal motor function is identified. More preferably, the mammal to which the administration is made has one or more ALS or MND symptoms and such one or more symptoms includes at least one of the observable motor functions being evaluated.
    Type: Application
    Filed: July 21, 2003
    Publication date: January 29, 2004
    Inventor: Mary E. Abood